Option Care Health, Inc. (OPCH)
NASDAQ: OPCH · Real-Time Price · USD
32.93
-0.61 (-1.82%)
Dec 16, 2025, 4:00 PM EST - Market closed
Option Care Health Stock Forecast
Stock Price Forecast
The 10 analysts that cover Option Care Health stock have a consensus rating of "Strong Buy" and an average price target of $36.3, which forecasts a 10.23% increase in the stock price over the next year. The lowest target is $27 and the highest is $41.
Price Target: $36.3 (+10.23%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Option Care Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 4 |
| Buy | 3 | 3 | 3 | 4 | 4 | 5 |
| Hold | 1 | 1 | 1 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 9 | 8 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Initiates $40 | Buy | Initiates | $40 | +21.47% | Dec 11, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $32 → $35 | Strong Buy | Maintains | $32 → $35 | +6.29% | Dec 9, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $31 → $36 | Strong Buy | Maintains | $31 → $36 | +9.32% | Dec 9, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $30 → $27 | Hold | Maintains | $30 → $27 | -18.01% | Nov 3, 2025 |
| Citizens | Citizens | Buy Maintains $38 → $36 | Buy | Maintains | $38 → $36 | +9.32% | Oct 31, 2025 |
Financial Forecast
Revenue This Year
5.75B
from 5.00B
Increased by 15.08%
Revenue Next Year
6.18B
from 5.75B
Increased by 7.44%
EPS This Year
1.75
from 1.23
Increased by 42.47%
EPS Next Year
1.91
from 1.75
Increased by 8.91%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.9B | 6.5B | |||
| Avg | 5.8B | 6.2B | |||
| Low | 5.5B | 5.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 18.6% | 12.7% | |||
| Avg | 15.1% | 7.4% | |||
| Low | 10.3% | 1.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.83 | 2.07 | |||
| Avg | 1.75 | 1.91 | |||
| Low | 1.67 | 1.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 48.5% | 18.0% | |||
| Avg | 42.5% | 8.9% | |||
| Low | 35.4% | -1.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.